Effectiveness of Tralokinumab for Upadacitinib-Refractory Atopic Dermatitis: 48-week Retrospective Study

Published: 15 July 2025| Version 1 | DOI: 10.17632/y98j2b9nw3.1
Contributors:
Teppei Hagino, Hidehisa Saeki,
, Naoko Kanda

Description

Supplementary Table 1. Baseline demographic and disease characteristics of patients with atopic dermatitis (n = 24)

Files

Institutions

  • Nihon Ika Daigaku Chiba Hokuso Byoin

Categories

Dermatology

Licence